Summary
A Manchester-based AI biotech spin-out has secured £5 million in funding to develop technology that aims to fundamentally transform chemical reactions. The company, which has emerged from the region's growing life sciences ecosystem, plans to leverage artificial intelligence to optimise chemical processes with significant implications for pharmaceuticals, manufacturing and sustainability. This investment represents a notable vote of confidence in Greater Manchester's biotech sector and highlights the region's emerging strength in AI-driven scientific innovation.
Read the full story at Prolific North
This is a summary written for the Manchester Business Services register. The full article belongs to Prolific North — read it at source.
Organisations mentioned
- Prolific North
Common questions
- What is this article about?
- A Manchester AI biotech spin-out has raised £5m to revolutionise chemical reactions using artificial intelligence, marking a significant investment in Greater Manchester's life sciences sector.
- When was this published?
- This article was published on 22 May 2026.
- Who published this article?
- This article was published by Prolific North.
- Which organisations does this article mention?
- This article mentions Prolific North.